🇺🇸 FDA
Patent

US 11161826

Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent

granted A61PA61P29/00

Quick answer

US patent 11161826 (Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent) held by ACADIA Pharmaceuticals Inc. expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADIA Pharmaceuticals Inc.
Grant date
Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P29/00